Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
30 Oct 2014  |  North America  |  Market Research
A Competitive Analysis of the Global Asthma and COPD Therapeutics Market
Novel Inhaler Devices and Formulations are Impetuses for Growth
This market insight provides a first-of-its-kind analysis of market sizing and revenue forecasts through 2016 for the prevalent Ebola virus. The number of people infected nears 10,000 globally, and the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) have deemed this the worst outbreak due to the death toll neari...
$3,950.00 -
10 Nov 2014  |  North America  |  Market Research
A Product and Pipeline Analysis of the Multiple Sclerosis Therapeutics Market
Launch of Several Pipeline Oral Products Could Diminish the Market for Injectable Therapies
This market insight provides data for the global multiple sclerosis (MS) market. The analysis looks at MS pharmaceutical pipeline drugs that are currently in the market as well as any drugs that are in Phase III trials and pose a potential threat to competitors. It offers a competitive analysis of these drugs and the forecasted outcome and impact o...
$3,950.00 -
15 Nov 2014  |  Asia Pacific  |  Market Research
Thailand In Vitro Diagnostics Market
Snapshot of Demand and Investment Opportunities
The report is expected to support the strategic decision makers in the In Vitro Diagnostic (IVD) market that are either planning to expand or enter Thailand. The forecast of the major segments can help the diagnostic companies decide their next five years business plan. Segments in the market include molecular diagnostics, immunochemistry, and mic...
$2,450.00 -
20 Nov 2014  |  North America  |  Market Research
Product and Pipeline Analysis of the Global Rheumatoid Arthritis Therapeutics Market
Launch of Novel Oral Therapies to Result in Major Market Changes
This market insight discusses the rheumatoid arthritis pharmaceutical drugs currently in the global market as well as those in the development stage. It offers a competitive analysis of the drugs and a forecast of their impact on the market. Drugs in the development stage are segmented by clinical trial phase as well as by drug class. The study cov...
$3,950.00 -
21 Nov 2014  |  North America  |  Market Research
Analysis of the US LIMS Market
Pharmaceuticals and Biobanks Spur Market Revenue with Increasing Adoption of Thin-client Web-based Systems
The laboratory information management systems (LIMS) market in the United States has been a mature space for many years. The evolution of laboratory needs has spurred innovation in this industry, forcing vendors to change their approach toward consumers. Consumers have the option of choosing between thick-client (Web-enabled) solutions, thin-client...
$3,950.00 -
05 Dec 2014  |  North America  |  Market Research
US Hemostasis Market
Increase in the Number of Patients within the Healthcare System Triggers Reagent Market Growth
The Affordable Care Act has created an upswing in the number of patients entering the US healthcare system, boosting the volume of routine and specialized testing performed in laboratories. This market insight analyzes the instrumentation and reagent segment activity within the US hemostasis market. Key trends and a comparative analysis between the...
$2,450.00 -
16 Dec 2014  |  Europe  |  Market Research
The Russian Biopharmaceuticals and Biomedicine Market
From Import Substitution to Innovation
This study explores Western Europes dynamic next generation sequencing (NGS) market. The majority of the quantitative and qualitative information was acquired through primary research conducted with NGS providers. The market is broadly classified into 2 major segments: instruments and reagents, and 2 subsegments: research use only and clinical dia...
$1,500.00 -
19 Dec 2014  |  Asia Pacific  |  Market Research
Patent Cliff and the Future of Generics in Asia
Trends that will Impact the Market in the Short Term
The global generics industry is in an interesting phase. Prescription volumes for generics are rising in the US and European markets, while regional manufacturers are struggling to meet demand. However, while Asian prescription volumes are lower than that of Western markets, Asian manufacturers are catering to domestic markets and exporting a signi...
$2,450.00 -
31 Dec 2014  |  North America  |  Market Research
US Liquid Handling Market
Strategies to Drive Growth in an Increasingly Competitive Market
The total market, as defined by this study, includes automated robotic workstations, low-to-mid throughput automated tools, and manual pipettes and consumables in the United States. The study period runs from 2011 to 2021, with 2014 as base year of 2014 and 20152021 as forecast period. This research service offers a discussion of the key market dr...
$3,950.00 -
14 Jan 2015  |  Asia Pacific  |  Market Research
Indonesia Healthcare Outlook
Value Propositions and Market Entry Guides for Investors
Indonesia has become one of the most attractive markets for investors during 2014-2015. Implementation of the Jaminan Kesehatan Nasional (JKN) scheme, initiated in January 2014, has been one of the major drivers besides the initiatives by the new government elected in 2014. As per the initial reports, patient volumes have significantly increased af...
$3,950.00